

Page 36
conferenceseries
.com
Volume 2, Issue 2 (Suppl)
Optom open access
ISSN: 2476-2075 OMOA, an open access journal
Ophthalmologists 2017
September 25-26, 2017
September 25-26, 2017 Dubai, UAE
11
th
Global
Ophthalmologists Annual Meeting
Inhaled corticosteroids and intraocular pressure: Is it more than what meets the eye?
Sujani Shroff
Aravind Eye Hospital, India
Introduction & Aim:
Glaucoma is the leading cause of irreversible blindness worldwide. Extensive studies have proved that
systemic and topical steroids play an important role in the pathogenesis of glaucoma. However little is known about the
effect of inhalational route. Our study was aimed to detect if there is truly an association between inhalational steroids and
intraocular pressure (IOP).
Design:
Cross sectional case control study of 200 patients visiting the pulmonologist and 200 controls among the general
population.
Methods:
Patients on inhaled corticosteroids 800 mcg equivalent of Budesonide or more for a period >6 months with no
usage of oral or topical steroids within the last 3 months were included as cases. Controls were recruited from the general
ophthalmological department with no previous steroid usage. IOP and central corneal thickness (CCT) was analyzed. Cases
were divided into two groups. Group-1: IOP<21 mm of Hg and Cup disc ratio (CDR) <0.4. Group-2: IOP>21 mm of Hg or with
CDR>0.5. Analysis was done within these two groups to find if there was an increased risk of developing ocular hypertension/
glaucoma with duration of inhaled steroids.
Results:
Statistically significant difference (p<0.001) was found between adjusted IOP of the controls [14.47 mm of Hg (±2.17)]
and cases [16.78 mm of Hg (±3.42)]. CCT among the cases was 522.02 microns (±30.47) which was lower compared to the
controls with 528.73 microns (±29.09). Our study found 11 patients with ocular hypertension and 2 patients with primary
open angle glaucoma. However, it showed no statistically significant correlation between duration of inhaled steroids usage
and increased risk for ocular hypertension/glaucoma.
Conclusion:
These findings suggest a probable association between inhalational steroids and intraocular pressure. Therefore, it
is advisable to measure baseline IOPs and CCT of all patients on inhaled corticosteroids and review them at regular intervals.
Biography
Sujani Shroff is a Budding Ophthalmologist who is doing her Fellowship in Glaucoma in Aravind Eye Hospital Madurai, India. She has keen interest in glaucoma
research and is currently working on several research projects in her institute. She has recently completed her Post-graduation from St. John’s Medical College,
India. Her research interest is to explore opportunities to learn and contribute in the field of glaucoma.
sujani88@gmail.comSujani Shroff, Optom open access 2017, 2:2 (Suppl)
DOI: 10.4172/2476-2075-C1-005